EU agency rejects study criticising patient organisations' commercial links
This article was originally published in SRA
The European Medicines Agency has rejected the conclusions of a survey by the civil society organisation Health Action International (HAI) claiming that the EMA is not doing enough to ensure that its patient and consumer stakeholder organisations are transparent in their disclosure of funds received from industry.
You may also be interested in...
In addition to agreeing to emergency use of the Oxford University/Astra Zeneca and Sinovac vaccines, Brazil's medicines regulator has also published good manufacturing practices certificates for Pfizer and Janssen vaccine. It has questions about the Sputnik V authorization request.
A Dutch parallel registration and reimbursement pilot has brought benefits including more participation from healthcare professionals, and also forces company divisions to be less streamlined.
The UK’s withdrawal from the EU could upset the Unitary Patent Court project.